Drug Shortage Report for ZYMAR
| Report ID | 271370 |
| Drug Identification Number | 02257270 |
| Brand name | ZYMAR |
| Common or Proper name | ZYMAR |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | GATIFLOXACIN |
| Strength(s) | 0.3% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5 mL |
| ATC code | S01AE |
| ATC description | ANTIINFECTIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-11-11 |
| Estimated end date | 2026-01-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-11-12 | English | Compare |
| v3 | 2025-11-10 | French | Compare |
| v2 | 2025-11-10 | English | Compare |
| v1 | 2025-11-10 | English | Compare |
Showing 1 to 4 of 4